aap Implantate Future Growth
Future criteria checks 1/6
aap Implantate is forecast to grow earnings and revenue by 44.4% and 11% per annum respectively. EPS is expected to grow by 48% per annum. Return on equity is forecast to be -11.7% in 3 years.
Key information
44.4%
Earnings growth rate
48.0%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 11.0% |
Future return on equity | -11.7% |
Analyst coverage | Low |
Last updated | 18 Jan 2024 |
Recent future growth updates
Recent updates
Investors Give aap Implantate AG (ETR:AAQ1) Shares A 26% Hiding
Jun 15One Analyst Just Shaved Their aap Implantate AG (ETR:AAQ1) Forecasts Dramatically
Aug 20Is aap Implantate (ETR:AAQ1) Weighed On By Its Debt Load?
Apr 04Here's Why aap Implantate (ETR:AAQ1) Can Afford Some Debt
Dec 06Is aap Implantate (ETR:AAQ1) Using Too Much Debt?
Aug 23aap Implantate (ETR:AAQ1) Is Carrying A Fair Bit Of Debt
May 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 17 | N/A | N/A | N/A | 1 |
12/31/2025 | 15 | -1 | 0 | 0 | 1 |
12/31/2024 | 13 | -2 | -2 | -2 | 1 |
12/31/2023 | 11 | -4 | -3 | -2 | 1 |
6/30/2023 | 12 | -2 | -2 | -2 | N/A |
3/31/2023 | 12 | -2 | -2 | -2 | N/A |
12/31/2022 | 12 | -3 | -2 | -2 | N/A |
9/30/2022 | 11 | -3 | -3 | -3 | N/A |
6/30/2022 | 11 | -4 | -4 | -3 | N/A |
3/31/2022 | 12 | -3 | -4 | -3 | N/A |
12/31/2021 | 12 | -3 | -3 | -2 | N/A |
9/30/2021 | 12 | -3 | -3 | -2 | N/A |
6/30/2021 | 12 | -4 | -3 | -2 | N/A |
3/31/2021 | 11 | -6 | -3 | -3 | N/A |
12/31/2020 | 9 | -9 | -4 | -4 | N/A |
9/30/2020 | 10 | -15 | -5 | -5 | N/A |
6/30/2020 | 11 | -21 | -7 | -6 | N/A |
3/31/2020 | 11 | -21 | -8 | -6 | N/A |
12/31/2019 | 13 | -19 | -7 | -6 | N/A |
9/30/2019 | 13 | -14 | -8 | -6 | N/A |
6/30/2019 | 13 | -8 | -8 | -5 | N/A |
3/31/2019 | 14 | -7 | -7 | -5 | N/A |
12/31/2018 | 13 | -8 | -9 | -6 | N/A |
9/30/2018 | 13 | -8 | -7 | -5 | N/A |
6/30/2018 | 13 | -8 | -7 | -5 | N/A |
3/31/2018 | 12 | -9 | -7 | -6 | N/A |
12/31/2017 | 12 | -9 | -7 | -5 | N/A |
9/30/2017 | 11 | -9 | -6 | -7 | N/A |
6/30/2017 | 11 | -9 | -6 | -6 | N/A |
3/31/2017 | 13 | -9 | N/A | -6 | N/A |
12/31/2016 | 12 | -9 | N/A | -7 | N/A |
9/30/2016 | 13 | -11 | N/A | -5 | N/A |
6/30/2016 | 14 | -11 | N/A | -3 | N/A |
3/31/2016 | 14 | -10 | N/A | -5 | N/A |
12/31/2015 | 14 | -10 | N/A | -2 | N/A |
9/30/2015 | 5 | -12 | N/A | -3 | N/A |
6/30/2015 | 9 | -10 | N/A | -5 | N/A |
3/31/2015 | 14 | -7 | N/A | -2 | N/A |
12/31/2014 | 17 | -6 | N/A | -3 | N/A |
9/30/2014 | 33 | 0 | N/A | -1 | N/A |
6/30/2014 | 31 | 0 | N/A | -2 | N/A |
3/31/2014 | 30 | -1 | N/A | 4 | N/A |
12/31/2013 | 33 | 1 | N/A | 4 | N/A |
9/30/2013 | 21 | 1 | N/A | 3 | N/A |
6/30/2013 | 25 | 1 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AAQ1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AAQ1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AAQ1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AAQ1's revenue (11% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: AAQ1's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AAQ1 is forecast to be unprofitable in 3 years.